Nicox SA (NICXF)
0.44
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Nicox Debt to Equity Ratio: 0.4477 for June 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.4477 |
| December 31, 2022 | 0.3916 |
| June 30, 2022 | 0.3395 |
| December 31, 2021 | 0.2716 |
| June 30, 2021 | 0.1969 |
| December 31, 2020 | 0.1783 |
| June 30, 2020 | 0.1852 |
| December 31, 2019 | 0.1018 |
| June 30, 2019 | 0.0644 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| December 31, 2015 | 0.0015 |
| June 30, 2015 | 0.00 |
| December 31, 2014 | 0.0033 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0644
Minimum
Jun 2019
0.4477
Maximum
Jun 2023
0.2419
Average
0.1969
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 0.3968 |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 0.9462 |
| Innate Pharma SA | 0.7525 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 89.42M |
| Total Liabilities (Quarterly) | 39.94M |
| Shareholders Equity (Quarterly) | 49.48M |
| Current Ratio | 2.572 |
| Net Debt Paydown Yield | 1.13% |